Kandu Health and Neurolutions Merge to Form Kandu, Inc.; $30M Financing Co‑Led by Ally Bridge Group and AMED Ventures

Boston Scientific to Acquire Nalu Medical, Inc.

October 17, 2025

Healthcare Services

Boston Scientific entered into a definitive agreement to acquire Nalu Medical, Inc., a privately held medical technology company focused on minimally invasive chronic pain neuromodulation. The deal includes an upfront cash payment of approximately $533 million for the remaining equity not already owned by Boston Scientific, with Boston Scientific expecting closing in the first half of 2026.

NLS Pharmaceutics Announces Merger With Kadimastem to Create NewcelX

June 27, 2025

Healthcare Services

NLS Pharmaceutics Ltd. (NASDAQ: NLSP) and Kadimastem Ltd. (TASE: KDST) are progressing toward a merger to form a combined Nasdaq-listed biotechnology company to be named NewcelX. The deal combines NLS’s DOXA dual orexin receptor agonist (AEX-2/AEX-41) CNS platform with Kadimastem’s cell-therapy pipeline (AstroRx for ALS and IsletRx for diabetes), and the companies are using committed equity financing to support the transaction and clinical development.

Sonde Health Acquires NeuroLex Laboratories

August 25, 2020

Healthcare Services

Sonde Health has acquired NeuroLex Laboratories, bringing NeuroLex's web-based voice survey platform, SurveyLex, and its biobank into Sonde's vocal biomarker technology suite. The deal combines NeuroLex's dataset and web capabilities with Sonde's mobile and voice-assistant platforms to expand research, data assets, and cross-platform voice-enabled health detection and monitoring.

KRTL Holding Group Acquires Neurogen Brain Balancing, LLC

April 9, 2025

Healthcare Services

KRTL Holding Group Inc. has acquired 100% of Neurogen Brain Balancing, LLC, a California-based neurotechnology company that provides non-invasive brain balancing therapies and personalized cognitive optimization systems. The stock-based transaction includes a profit-sharing agreement and KRTL will support Neurogen's regulatory pathway and international expansion, including FDA-related services and integration into KRTL's operational infrastructure.

MedEdge Holdings Formed Through $450 Million Management-Led Buyout of Abyrx and Kairuku

November 24, 2025

Medical Devices

Abyrx, Inc. and Kairuku, Inc. completed a combined $450 million management-led buyout and capital raise to form MedEdge Holdings LLC. The new holding company will integrate Abyrx's biosurgical product portfolio with Kairuku's SaaS commercial operations platform and deploy capital to acquire 10–15 commercial-stage surgical product companies to accelerate growth and streamline product delivery to operating rooms.

Nihon Kohden Acquires 71.4% Stake in Ad‑Tech from ARCHIMED

November 26, 2024

Medical Devices

Nihon Kohden has acquired a 71.4% stake in NeuroAdvanced Corp., the parent of Ad‑Tech Medical Instrument Corporation, from ARCHIMED’s MED II fund, with ARCHIMED retaining a 28.6% minority stake and entering a joint venture with Nihon Kohden. The deal brings together Nihon Kohden’s EEG and monitoring platform with Ad‑Tech’s intracranial neuroelectrodes to strengthen epilepsy diagnostics and expand Ad‑Tech’s global reach across North America, Europe and Asia.